Metraipolis › archive › dc_92c8381e2768

Risk Stratification and Factors Associated with Heart Failure Hospitalization During Osimertinib Therapy — Europe PMC PMID:42930153

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42930153
DOI
10.3390/curroncol33100586
License (as archived)
solo-consultazione
Archived
2026-10-31T13:57:17.102Z
SHA-256 of the archived text
af5c24ecb69482bdc14fe063c3d5173fea6e2de295c3b579f7492694a22aa201
Stable URL of this page
https://metraipolis.com/documento/dc_92c8381e2768

How to cite

Risk Stratification and Factors Associated with Heart Failure Hospitalization During Osimertinib Therapy — Europe PMC PMID:42930153 — Europe PMC (en), https://europepmc.org/article/MED/42930153 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_92c8381e2768 (Metraipolis archive dc_92c8381e2768, sha256 af5c24ecb69482bdc14fe063c3d5173fea6e2de295c3b579f7492694a22aa201)
BibTeX
@misc{dc92c8381e2768,
  title = {Risk Stratification and Factors Associated with Heart Failure Hospitalization During Osimertinib Therapy — Europe PMC PMID:42930153},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42930153},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_92c8381e2768; sha256 af5c24ecb69482bdc14fe063c3d5173fea6e2de295c3b579f7492694a22aa201},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42930153. Agents can read the archived copy with the MCP tool read_document.